Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...

When certified dog trainer Nanette Lai had an MS flare, she figured out workarounds to allow her to still take care of her ...

Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says ...

You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...

Founded in 1946, the National Multiple Sclerosis Society funds cutting-edge research, drives change through advocacy, and provides programs and services to help people affected by MS live their ...

After being diagnosed with Multiple Sclerosis over a decade ago one Chicago comedian is on a mission to help others with the ...

Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, ...

New research highlights a critical link between antibodies produced against Epstein-Barr virus (EBV) and the development of ...

Scientists from Sweden’s Karolinska Institutet have uncovered new clues about how the Epstein-Barr virus (EBV) might ...

The National Multiple Sclerosis Society says 2.3 million people have been diagnosed with the disease worldwide, but it ...

In multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and spinal cord. New research shows that the combination of certain viral ...

Biogen Inc. has disclosed uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists with improved brain penetration reported to be useful for the treatment of multiple sclerosis.